NEWS

For our visitors who seek the latest industry news and updates to keep abreast with the goings-on of the business on a global scale, Pharmaceutical Industry portal grants a dynamic and diverse feed of news items.

news

A once-monthly injection for multiple sclerosis from Biogen and AbbVie has been recommended for approval by European regulators, paving the way for its launch in the coming months. The European Medicines Agency said on Friday its experts had endorsed Zinbryta, or daclizumab, for the treatment of relapsing forms of multiple…

news

Alexion Pharmaceuticals Inc. reported profit fell amid continued economic weakness in Latin America, while expenses climbed. The company, which focuses on a narrow range of treatments for rare diseases, also said it expects profit and revenue for the year to come in at the low end of its previous guidance.…

news

Armed with Beijing funds and friends in the right places, Chinese drug minnows are thriving, luring money from 'Big Pharma' majors struggling to restore the strong growth they once enjoyed in the world's second-largest medicine market. Chinese healthcare mergers and acquisitions nearly tripled last year to more than $50 billion,…

news

Patients with Hemophilia A could soon look forward to a bigger basket of treatment options, with third-generation products by multinational companies like Novo Nordisk and Baxalta entering the Indian market this year. At the same time, the products may not be cost-effective for the benefits offered, say experts. While Novo…

news

Galapagos and abbvie expand their cystic fibrosis collaboration. Patient trials expected to start in 2017. Milestones increased from $350 to $600 million. Companies have expanded their agreement in cystic fibrosis (cf) to reflect successful expansion of their cf portfolio. Retains commercial rights to china and south korea, and has an…

news

Cumberland Pharmaceuticals announces new program to develop Vasculan for systemic sclerosis. U.S. FDA has cleared Cumberland's IND for PHASE II clinical program for Vasculan in patients with systemic sclerosis.   Source : reuters.com

news

ORIG3N, Inc., a pioneer in the field of regenerative medicine, opened its new headquarters and laboratory in Boston, Massachusetts. The facility is located at 27 Drydock Avenue within its Innovation and Design Building in the Seaport District. The company’s new expanded facility will provide state-of-the-art functionality to sustain collaborative research…

news

Activist investor William Ackman promised U.S. lawmakers on Wednesday that he will urge the board of Valeant Pharmaceuticals (VRX.TO) to reduce the high prices of four life-saving drugs that are now at the heart of two congressional probes. Speaking before the Senate Special Committee on Aging, Ackman revealed that Valeant's…

news

Pfizer Inc has agreed to pay $784.6 million to resolve allegations that Wyeth, which it acquired in 2009, underpaid drug rebates to Medicaid, the federal health insurance program, the Justice Department said on Wednesday. The settlement resolves claims by the U.S. and states that Wyeth knowingly reported false and fraudulent…

news

Eisai Pharmaceuticals India Pvt Ltd, which has a unit in the Jawahar Pharma city in Visakhapatnam district, has taken up an expansion project and is also introducing new drugs to the Indian market, according to Managing Director Sanjit Singh Lamba. The company is increasing its API (active pharma ingredient) plant…